CD19 and myelodysplastic syndrome: UF1837 (BM and PB) had an ambiguous flow cytometry panel with 35% myeloblasts and dim CD19 expression, which prompted concern for biphenotypic leukemia; predictions classified both samples as MDS-related; secondary myeloid with high confidence (BM: 0.827, PB: 0.891).